President Donald Trump has signed an executive order that he claims will cut prescription drug prices supplied to the US to ...

A digital therapy that could reduce the severity of chronic tic disorders like Tourette syndrome has been recommended for use ...

Tom Keith-Roach, president of AZ's UK business, said: "The UK approval of Trixeo Aerosphere with the [new] propellant marks a ...

"We can use…AI to estimate a person's biological age from face pictures, and our study shows that information can be ...

A larger waist circumference is associated with a higher risk of all-cause mortality and decreased life expectancy. Meanwhile ...

Gilead Sciences has joined the list of pharma groups hiking their capital investment plans in the US, adding $11 billion in new spending as the industry prepares for potential sector-specific tariffs.

These have been dark days for the global economy, and the short-term prospects for the pharmaceutical industry look uncertain. The industry is currently undergoing change and restructuring on an ...

Sky-high sales prospects for Bristol Myers Squibb's new schizophrenia treatment Cobenfy may have to be scaled down after a trial designed to expand the label of the recently approved drug failed.

Italfarmaco's oral HDAC inhibitor Duvyzat has been recommended for approval in the EU as a treatment for Duchenne muscular dystrophy (DMD), setting it on course to become the first non-steroidal ...

Plaintiff Todd Engel pictured with his wife and daughter. A Maryland man who has lost his vision due to non-arteritic anterior ischaemic optic neuropathy (NAION) is suing Novo Nordisk, alleging ...

Roche has said it will spend $50 billion on manufacturing and R&D facilities in the US, with a pledge to export more medicines from the US than it imports once the investment programme is completed.